HCB-301

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameHCB-301
Drug Alias NameHCB-301HCB301
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHodgkin DiseaseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHanchorBio Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursHodgkin Disease
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A